Canada Life’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247M | Buy |
|
|||||
|
2025
Q1 | $246M | Buy |
|
|||||
|
2024
Q4 | $194M | Sell |
|
|||||
|
2024
Q3 | $182M | Buy |
|
|||||
|
2024
Q2 | $146M | Buy |
|
|||||
|
2024
Q1 | $133M | Buy |
|
|||||
|
2023
Q4 | $144M | Sell |
|
|||||
|
2023
Q3 | $136M | Buy |
|
|||||
|
2023
Q2 | $140M | Buy |
|
|||||
|
2023
Q1 | $135M | Buy |
|
|||||
|
2022
Q4 | $136M | Sell |
|
|||||
|
2022
Q3 | $122M | Sell |
|
|||||
|
2022
Q2 | $124M | Sell |
|
|||||
|
2022
Q1 | $127M | Buy |
|
|||||
|
2021
Q4 | $139M | Buy |
|
|||||
|
2021
Q3 | $120M | Buy |
|
|||||
|
2021
Q2 | $116M | Sell |
|
|||||
|
2021
Q1 | $118M | Sell |
|
|||||
|
2020
Q4 | $127M | Buy |
|
|||||
|
2020
Q3 | $131M | Sell |
|
|||||
|
2020
Q2 | $160M | Sell |
|
|||||
|
2020
Q1 | $165M | Buy |
|
|||||
|
2019
Q4 | $140M | Buy |
|
|||||
|
2019
Q3 | $118M | Buy |
|
|||||
|
2019
Q2 | $122M | Sell |
|
|||||
|
2019
Q1 | $118M | Buy |
|
|||||
|
2018
Q4 | $99.1M | Sell |
|
|||||
|
2018
Q3 | $148M | Sell |
|
|||||
|
2018
Q2 | $145M | Buy |
|
|||||
|
2018
Q1 | $147M | Sell |
|
|||||
|
2017
Q4 | $141M | Buy |
|
|||||
|
2017
Q3 | $148M | Buy |
|
|||||
|
2017
Q2 | $125M | Buy |
|
|||||
|
2017
Q1 | $113M | Sell |
|
|||||
|
2016
Q4 | $123M | Buy |
|
|||||
|
2016
Q3 | $125M | Buy |
|
|||||
|
2016
Q2 | $129M | Buy |
|
|||||
|
2016
Q1 | $119M | Buy |
|
|||||
|
2015
Q4 | $130M | Buy |
|
|||||
|
2015
Q3 | $124M | Buy |
|
|||||
|
2015
Q2 | $125M | Buy |
|
|||||
|
2015
Q1 | $100M | Sell |
|
|||||
|
2014
Q4 | $100M | Sell |
|
|||||
|
2014
Q3 | $147M | Sell |
|
|||||
|
2014
Q2 | $119M | Sell |
|
|||||
|
2014
Q1 | $115M | Buy |
|
|||||
|
2013
Q4 | $96M | Sell |
|
|||||
|
2013
Q3 | $80.8M | Buy |
|
|||||
|
2013
Q2 | $23.9M | Buy |
|